Literature DB >> 16162947

The promise and perils of interpreting genetic associations in Crohn's disease.

T T Trinh1, J D Rioux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16162947      PMCID： PMC1774681          DOI： 10.1136/gut.2005.070920

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  33 in total

1.  International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16.

Authors:  J Cavanaugh
Journal:  Am J Hum Genet       Date:  2001-04-12       Impact factor: 11.025

2.  Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.

Authors:  R Kekuda; P D Prasad; X Wu; H Wang; Y J Fei; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

3.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

4.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.

Authors:  J D Rioux; M S Silverberg; M J Daly; A H Steinhart; R S McLeod; A M Griffiths; T Green; T S Brettin; V Stone; S B Bull; A Bitton; C N Williams; G R Greenberg; Z Cohen; E S Lander; T J Hudson; K A Siminovitch
Journal:  Am J Hum Genet       Date:  2000-04-21       Impact factor: 11.025

5.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Authors:  J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Molecular and functional characterization of organic cation/carnitine transporter family in mice.

Authors:  I Tamai; R Ohashi; J I Nezu; Y Sai; D Kobayashi; A Oku; M Shimane; A Tsuji
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

9.  cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.

Authors:  X Wu; P D Prasad; F H Leibach; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1998-05-29       Impact factor: 3.575

10.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321
View more
  1 in total

1.  Lack of association of MYO9B genetic variants with coeliac disease in a British cohort.

Authors:  K A Hunt; A J Monsuur; W L McArdle; P J Kumar; S P L Travis; J R F Walters; D P Jewell; D P Strachan; R J Playford; C Wijmenga; D A van Heel
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.